APA (7th ed.) Citation

K, S., R, K., E, P., CL, C., JG, T., J, Z., . . . JE, L. (2020). Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 26(1), 54. https://doi.org/10.1158/1078-0432.CCR-19-2169

Chicago Style (17th ed.) Citation

K, Sweet, et al. "Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 26, no. 1 (2020): 54. https://doi.org/10.1158/1078-0432.CCR-19-2169.

MLA (9th ed.) Citation

K, Sweet, et al. "Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 26, no. 1, 2020, p. 54, https://doi.org/10.1158/1078-0432.CCR-19-2169.